Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Roche
 More »

  • Novartis Inks Agreement for ImmunoGen's "TAP" ADC Technology
    The first product applying ImmunoGen's TAP technology is the Roche drug Kadcyla® (T-DM1 ... by the FDA in February and marketed in the United States by Roche subsidiary Genentech. ...
    10-11-2013
  • Ovarian Cancer Treatment Options Multiply
    ... 60% of the ovarian cancer therapeutic market by 2021, according to Decision Resources. Avastin® by Roche/Genentech/Chugai and trebananib by Amgen were cited as leading contenders. ...
    10-8-2013
  • Young Companies in the Money: 25 Firms to Watch
    ... Additional financing participants: Existing investors Fountain Healthcare Partners, Roche Venture Fund, and Seroba Kernel Life Sciences; and new investors Sunstone Capital, ...
    10-2-2013
  • Purification Column for Histidine-Tagged Proteins
    Roche 9115 Hague Rd UNITED STATES IN 46250 Roche Applied Science offers a selection of advanced research tools that accelerate life science discovery. Roche Applied Science offers ...
    10-1-2013
  • Malvern Instruments Acquires NanoSight
    As of May, NanoSight had installed more than 600 systems worldwide for customers that include pharma giants such as GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Roche, as ...
    9-30-2013
  • Roche, Pac Bio in Up to $75M Clinical Diagnostics Deal
    More than a year after Roche tried but failed to buy DNA-sequencing product leader ... Roche tried but failed twice last year to buy Illumina, whose board rejected offers for ...
    9-25-2013
  • AstraZeneca Licenses 3 X-Chem Drug Discovery Programs
    Besides AZ, X-Chem has disclosed only one of those partners. In 2010, Roche agreed to ... payments and royalties based on worldwide sales of products developed with Roche. ...
    9-24-2013
  • Takeover Targets: Who Is First on the List?
    ... Deal Reporter story September 19 that Roche was looking to acquire the company with ... BioMarin dismissed the report as "rumors" and declined comment; Roche also refused ...
    9-24-2013
  • Google Eyes Wider Healthcare Footprint with Tech-Focused Calico
    Google is looking beyond investments to expand its footprint in healthcare, with its decision to launch a new company focused on developing technologies to fight aging and ...
    9-19-2013
  • FDA Panel Urges Fast Approval of Perjeta for Early-Stage Breast...
    Genentech, a subsidiary of Roche, won FDA approval in June 2012 for Perjeta, but for use ... ODAC said its recommendation was based on results submitted by Roche Genentech from two ...
    9-13-2013
  • Roche Signs Up to $422.5M Collaboration with Inovio
    Roche and Inovio Pharmaceuticals said today they formed an up-to-$422.5 million ... and INO-1800 targeting hepatitis B. Roche also agreed to license Inovio's ...
    9-10-2013
  • Transfection Methods Evolving
    ... The Roche Applied Science X-tremeGENE transfection reagents contain components that ... R&D, technology & innovation group, at Roche Applied Science. "As more cell-based ...
    9-1-2013
  • BEAMing for Cancer
    ... polymerase and 6-fold lower than that of Pfu DNA polymerase, as determined by a modified lacI-based method ( Figure 2 ) and later confirmed using Roche/454 and Illumina sequencing. ...
    9-1-2013
  • Top Biotech & Pharma Companies
    have outpaced Big Pharma (e.g., Johnson & Johnson, Pfizer, Roche, Novartis, and Sanofi) in terms of growth of sales, income, and investment in R&D during the past three years. ...
    9-1-2013
  • Spreading Sunshine on What Biopharma Pays Physicians
    ... ProPublica has tallied more than $2 billion from 15 biopharmas since 2009. Until the Sunshine Act, some drug giants including Amgen, Bayer, Sanofi, and Roche disclosed no payment ...
    8-29-2013
  • More »

    Journal Articles

  • Performance of the Roche Accu-Chek Active Glucose Meter to Screen...
    Gurdeep S. Dhatt, Mukesh M. Agarwal, Yusra Othman, Satish C. Nair
    Diabetes Technology & Therapeutics
    Performance of the Roche Accu-Chek Active Glucose Meter to Screen for Gestational Diabetes ... We report the performance and effectiveness of the Accu-Chek® Active (Roche Diagnostics ...
  • The Roche Elecsys and Siemens-Centaur Thyroglobulin Autoantibody...
    Alicia Algeciras-Schimnich, Michael A. Lasho, Karl M. Ness, Lynn A. Cheryk, Stefan K.G. Grebe
    Thyroid
    The Roche Elecsys and Siemens-Centaur Thyroglobulin Autoantibody Assays Show Comparable Clinical Performance to the Recently Unavailable Beckman-Coulter Access Thyroglobulin ...
  • Clinical Performance of Three Bolus Calculators in Subjects with...
    Howard Zisser, Robin Wagner, Stefan Pleus, Cornelia Haug, Nina Jendrike, Chris Parkin, Matthias Schweitzer, Guido Freckmann
    Diabetes Technology & Therapeutics
    We compared the efficacy of three ABCs (Accu-Chek® Combo [Roche Insulin Delivery Systems (IDS), Inc., Fishers, IN, a member of the Roche Group], Animas® 2020 [Animas Corp., West ...
  • Interference Studies with Two Hospital-Grade and Two Home-Grade...
    Martha E. Lyon, Leland B. Baskin, Sandy Braakman, Steven Presti, Jeffrey Dubois, Terry Shirey
    Diabetes Technology & Therapeutics
    MA] StatStrip(tm) [hospital grade], Roche Diagnostics [Indianapolis, IN] Accu-Chek ... laboratory plasma hexokinase reference method (Roche Hitachi 912® chemistry analyzer). ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll